5 Murk A J, Rijntjes E, Blaauboer B J, et al. Mechanism-based testing strategy using in vitro approaches for identification of thyroid hormone disrupting chemicals. Toxicol In Vitro, 2013, 27: 1320-1346
[2]
9 Auffinger P, Hays F A, Westhof E, et al. Halogen bonds in biological molecules. Proc Natl Acad Sci USA, 2004, 101: 16789-16794
[3]
10 Metrangolo P, Resnati G. Halogen versus hydrogen. Science, 2008, 321: 918-919
[4]
22 Brouwer A, Morse D C, Lans M C, et al. Interactions of persistent environmental organohalogens with the thyroid hormone system: Mechanisms and possible consequences for animal and human health. Toxicol Ind Health, 1998, 14: 59-84
[5]
23 Kodavanti P R, Curras-Collazo M C. Neuroendocrine actions of organohalogens: Thyroid hormones, arginine vasopressin, and neuroplasticity. Front Neuroendocrinol, 2010, 31: 479-496
[6]
24 Li F, Xie Q, Li X H, et al. Hormone activity of hydroxylated polybrominated diphenyl ethers on human thyroid receptor-beta: In vitro and in silico investigations. Environ Health Perspect, 2010, 118: 602-606
[7]
25 Gl？ttli A, Daura X, Seebach D, et al. Can one derive the conformational preference of a beta-peptide from its CD spectrum? J Am Chem Soc, 2002, 124: 12972-12978
[8]
26 Verma R P, Hansch C. Use of 13C NMR chemical shift as QSAR/QSPR descriptor. Chem Rev, 2011, 111: 2865-2899
[9]
28 Rayne S, Forest K. pKa values of the monohydroxylated polychlorinated biphenyls (OH-PCBs), polybrominated biphenyls (OH-PBBs), polychlorinated diphenyl ethers (OH-PCDEs), and polybrominated diphenyl ethers (OH-PBDEs). J Environ Sci Health A Tox Hazard Subst Environ Eng, 2010, 45: 1322-1346
[10]
1 Ren X M, Guo L H. Assessment of the binding of hydroxylated polybrominated diphenyl ethers to thyroid hormone transport proteins using a site-specific fluorescence probe. Environ Sci Technol, 2012, 46: 4633-4640
[11]
2 Patrick L. Thyroid disruption: Mechanism and clinical implications in human health. Altern Med Rev, 2009, 14: 326-346
[12]
3 Boas M, Feldt-Rasmussen U, Main K M. Thyroid effects of endocrine disrupting chemicals. Mol Cell Endocrinol, 2012, 355: 240-248
[13]
4 Mortimer R H, Landers K A, Balakrishnan B, et al. Secretion and transfer of the thyroid hormone binding protein transthyretin by human placenta. Placenta, 2012, 33: 252-256
[14]
6 Weiss J M, Andersson P L, Lamoree M H, et al. Competitive binding of poly- and perfluorinated compounds to the thyroid hormone transport protein transthyretin. Toxicol Sci, 2009, 109: 206-216
[15]
7 Hamers T, Kamstra J H, Sonneveld E, et al. In vitro profiling of the endocrine-disrupting potency of brominated flame retardants. Toxicol Sci, 2006, 92: 157-173
[16]
8 Yang X H, Xie H B, Chen J W, et al. Anionic phenolic compounds bind stronger with transthyretin than their neutral forms: Nonnegligible mechanisms in virtual screening of endocrine disrupting chemicals. Chem Res Toxicol, 2013, 26: 1340-1347
[17]
11 Lu Y X, Shi T, Wang Y, et al. Halogen bonding: A novel interaction for rational drug design? J Med Chem, 2009, 52: 2854-2862
[18]
12 Lu Y, Wang Y, Xu Z J, et al. C-X…H contacts in biomolecular systems: How they contribute to protein-ligand binding affinity. J Phys Chem B, 2009, 113: 12615-12621
[19]
13 Lu Y, Wang Y, Zhu W L. Nonbonding interactions of organic halogens in biological systems: Implications for drug discovery and biomolecular design. Phys Chem Chem Phys, 2010, 12: 4543-4551
[20]
14 Parisini E, Metrangolo P, Pilati T, et al. Halogen bonding in halocarbon-protein complexes: A structural survey. Chem Soc Rev, 2011, 40: 2267-2278
[21]
15 Zhou P, Tian F, Zou J, et al. Rediscovery of halogen bonds in protein-ligand complexes. Min Rev Med Chem, 2010, 10: 309-314
[22]
16 Voth A R, Hays F A, Ho P S. Directing macromolecular conformation through halogen bonds. Proc Natl Acad Sci USA, 2007, 104: 6188-6193
[23]
17 Hardegger L A, Kuhn B, Spinnler B, et al. Systematic investigation of halogen bonding in protein-ligand interactions. Angew Chem Int Ed, 2011, 50: 314-318
[24]
18 Scholfield M R, Zanden C M, Carter M, et al. Halogen bonding (X-bonding): A biological perspective. Protein Sci, 2013, 22: 139-152
[25]
19 Ibrahim M A. AMBER empirical potential describes the geometry and energy of noncovalent halogen interactions better than advanced semiempirical quantum mechanical method PM6-DH2X. J Phys Chem B, 2012, 116: 3659-3669
[26]
20 Carter M, Rappe A K, Ho P S. Scalable anisotropic shape and electrostatic models for biological bromine halogen bonds. J Chem Theory Comput, 2012, 8: 2461-2473
[27]
21 Diamanti-Kandarakis E, Bourguignon J P, Giudice L C, et al. Endocrine-disrupting chemicals: An Endocrine Society scientific statement. Endocr Rev, 2009, 30: 293-342
[28]
27 袁履冰, 高占先, 陈宏博. 有机化学. 北京: 高等教育出版社, 1999. 309
[29]
29 Han J, Tao F M. Correlations and predictions of pKa values of fluorophenols and bromophenols using hydrogen-bonded complexes with ammonia. J Phys Chem A, 2006, 110: 257-263
[30]
30 Meylan W M, Howard P H. Atom/fragment contribution method for estimating octanol-water partition coefficients. J Pharm Sci, 1995, 84: 83-92
